S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Bio-Rad Laboratories, Inc.Class A

BIO XNYS
$352.47 +10.04 (+2.93%) ▲ 15-min delayed
Open
$339.18
High
$353.33
Low
$339.18
Volume
266.9K
Market Cap
$9.16B

About Bio-Rad Laboratories, Inc.Class A

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 7.5K Website →

Key Financials

Period Revenue Net Income EPS
Q2 2026 $651.00M $371.40M $13.89
FY 2025 $2.58B $759.90M $27.87
Q2 2025 $651.60M $317.80M $11.67
Q1 2025 $585.40M $64.00M $2.29

Related Market News

No specific coverage for BIO yet. Check out our latest market news or earnings calendar.

Get BIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bio-Rad Laboratories, Inc.Class A.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.